DR. DANIEL V SANTI, M.D., PH. D.
Hospitals at Belgrave Ave, San Francisco, CA
License number
California G48727
Category
Hospitals
Type
Chronic Disease Hospital
Address
Address
211 Belgrave Ave, San Francisco, CA 94117
Phone
(415) 533-5775
Personal information
See more information about DANIEL V SANTI at radaris.comName
Address
Phone
1382 Leggs Ln, Sonoma, CA 95476
211 Belgrave Ave, San Francisco, CA 94117
San Francisco, CA
211 Belgrave Ave, San Francisco, CA 94117
1382 Leggs Ln, Sonoma, CA 95476
Organization information
See more information about DANIEL V SANTI at bizstanding.comDANIEL V. SANTI, M.D., INC
211 Belgrave Ave, San Francisco, CA 94117
Status:
Inactive
Registration:
Oct 20, 1982
State ID:
C1125541
Business type:
Articles of Incorporation
President:
Daniel V. Santi President, inactive
Agent:
Lawrence D Imber,Walnut Creek, CA 94596 (Physical)
Professional information
Dr. Daniel V Santi, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
211 Belgrave Ave, San Francisco 94117
(415) 533-5775 (Phone)
(415) 533-5775 (Phone)
Languages:
English
Education:
Medical School
University of California At San Francisco
Graduated: 1981
University of California At San Francisco
Graduated: 1981
Polynucleotides Encoding The Fkba Gene Of The Fk-520 Polyketide Synthase Gene Cluster
US Patent:
6759536, Jul 6, 2004
Filed:
Aug 27, 2001
Appl. No.:
09/940316
Inventors:
Christopher Reeves - Orinda CA
Daniel Chu - Santa Clara CA
Chaitan Khosla - Palo Alto CA
Daniel Santi - San Francisco CA
Kai Wu - Foster City CA
Daniel Chu - Santa Clara CA
Chaitan Khosla - Palo Alto CA
Daniel Santi - San Francisco CA
Kai Wu - Foster City CA
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
C07D22118
US Classification:
546 71
Abstract:
Host cells comprising recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide. Recombinant DNA constructs comprising one or more FK-520 polyketide synthase domains, modules, open reading frames, and variants thereof can be used to produce recombinant polyketide synthases and a variety of different polyketides with application as pharmaceutical and veterinary products.
Method Of Obtaining Diagnostic Reagents, Assays And Therapeutics Based On Clinical Manifestations Of A Disease
US Patent:
5492807, Feb 20, 1996
Filed:
Nov 19, 1993
Appl. No.:
8/155943
Inventors:
Daniel V. Santi - San Francisco CA
International Classification:
C12Q 170
US Classification:
435 5
Abstract:
Antibodies are recovered and isolated from the sera of a number "n" of patients each of which have or have had the same given disease so that each of the "n" patients has, within a large number of different antibodies, some antibodies uniquely associated with the same disease of interest. The antibodies of a first patient are bound to a support surface. To carry out initial screening libraries of molecules are brought into contact with the bound antibodies of the first patient under conditions where binding will occur. Secondary screening is then carried out by extracting and labeling the antibodies of a second patient and using the labeled antibodies to probe the molecules (peptides) isolated in the initial screening. Many of the non-disease specific antibodies (of the second patient) will not bind to the molecules (peptides) of the isolated bacteriophage which bound to the antibodies of the first patient. Hence, the molecules (peptides) which are common to both patients with the same disease will be identified.
Polynucleotides Encoding The Fkbb Gene Of The Fk-520 Polyketide Synthase Gene Cluster
US Patent:
2009018, Jul 23, 2009
Filed:
Jul 6, 2004
Appl. No.:
10/885305
Inventors:
Christopher Reeves - Orinda CA, US
Daniel Chu - Santa Clara CA, US
Chaitan Khosla - Palo Alto CA, US
Daniel Santi - San Francisco CA, US
Kai Wu - Foster City CA, US
Daniel Chu - Santa Clara CA, US
Chaitan Khosla - Palo Alto CA, US
Daniel Santi - San Francisco CA, US
Kai Wu - Foster City CA, US
International Classification:
C12P 21/04, C12N 15/11, C12P 17/16, C12N 1/21, C12N 15/00
US Classification:
435 691, 536 231, 4353201, 435118, 43525235
Abstract:
Host cells comprising recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide. Recombinant DNA constructs comprising one or more FK-520 polyketide synthase domains, modules, open reading frames, and variants thereof can be used to produce recombinant polyketide synthases and a variety of different polyketides with application as pharmaceutical and veterinary products.
Production Of Polyketides In Bacteria And Yeast
US Patent:
6033883, Mar 7, 2000
Filed:
Dec 11, 1997
Appl. No.:
8/989332
Inventors:
Philip J. Barr - Oakland CA
Daniel V. Santi - San Francisco CA
Gary W. Ashley - Alameda CA
Rainer Ziermann - San Mateo CA
Daniel V. Santi - San Francisco CA
Gary W. Ashley - Alameda CA
Rainer Ziermann - San Mateo CA
Assignee:
KOSAN Biosciences, Inc. - Burlinggame CA
International Classification:
C12P 726, C12N 1554, C12N 1562, C12N 1581
US Classification:
435148
Abstract:
Hybrid and novel polyketide synthases and polyketides are produced by use of a multiple vector system. The combinatorial possibilities offered by placing the various catalytic activities of PKS systems on separate vectors permits the construction of improved libraries of PKS and polyketides. In addition, polyketides can be produced in hosts that ordinarily do not produce polyketides by supplying, along with an expression system for the desired PKS, an expression system for holo ACP synthase.
Pneumocystis Carinii Dihydrofolate Reductase Gene And Methods For Its Use
US Patent:
5164490, Nov 17, 1992
Filed:
Nov 15, 1989
Appl. No.:
7/437511
Inventors:
Daniel V. Santi - San Francisco CA
Jeffrey Edman - San Francisco CA
Ursula Edman - San Francisco CA
Jeffrey Edman - San Francisco CA
Ursula Edman - San Francisco CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07H 1512, C12P 2106, C12P 1936
US Classification:
536 27
Abstract:
Genetic material encoding dihydrofolate reductase (DHFR) of Pneumocystis carinii has been isolated and characterized. This genetic material allows the production of peptides for use in the design of inhibitors specific for P. carinii DHFR (as opposed to DHFR in the host infected with P. carinii) or can itself be directly used in hybridization assays.
Overproduction Hosts For Biosynthesis Of Polyketides
US Patent:
2005028, Dec 29, 2005
Filed:
Dec 21, 2004
Appl. No.:
11/019909
Inventors:
Daniel Santi - San Francisco CA, US
Robert McDaniel - Palo Alto CA, US
Li Tang - Foster City CA, US
Chaitan Khosla - Palo Alto CA, US
Robert McDaniel - Palo Alto CA, US
Li Tang - Foster City CA, US
Chaitan Khosla - Palo Alto CA, US
International Classification:
C12P019/62, C12N015/74, C12N001/21
US Classification:
435076000, 435252300, 435471000
Abstract:
Generic overproduction host cells can be used to produce any polyketide and obviate the need for performing conventional strain improvement.
Polyketide Synthase Enzymes And Recombinant Dna Constructs Therefor
US Patent:
RE39762, Aug 7, 2007
Filed:
Dec 9, 2005
Appl. No.:
11/299244
Inventors:
Christopher Reeves - Orinda CA, US
Daniel Chu - Santa Clara CA, US
Chaitan Khosla - Palo Alto CA, US
Daniel Santi - San Francisco CA, US
Kai Wu - Foster City CA, US
Daniel Chu - Santa Clara CA, US
Chaitan Khosla - Palo Alto CA, US
Daniel Santi - San Francisco CA, US
Kai Wu - Foster City CA, US
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
C07D 515/00, C07D 498/00
US Classification:
546 92, 546 90
Abstract:
Polyketide compounds of the formula but not including FK-506, FK-520, 18-hydroxy-FK520 and 18-hydroxy-FK-506.
Production Of Polyketides
US Patent:
2003007, Apr 17, 2003
Filed:
Sep 19, 2001
Appl. No.:
09/957483
Inventors:
Robert Arslanian - Pacifica CA, US
Gary Ashley - Alameda CA, US
Scott Frykman - Hayward CA, US
Bryan Julien - Oakland CA, US
Leonard Katz - Oakland CA, US
Chaitan Khosla - Palo Alto CA, US
Janice Lau - San Mateo CA, US
Peter Licari - Fremont CA, US
Rika Regentin - Hayward CA, US
Daniel Santi - San Francisco CA, US
Li Tang - Foster City CA, US
Gary Ashley - Alameda CA, US
Scott Frykman - Hayward CA, US
Bryan Julien - Oakland CA, US
Leonard Katz - Oakland CA, US
Chaitan Khosla - Palo Alto CA, US
Janice Lau - San Mateo CA, US
Peter Licari - Fremont CA, US
Rika Regentin - Hayward CA, US
Daniel Santi - San Francisco CA, US
Li Tang - Foster City CA, US
International Classification:
C12P017/00, C12P017/02, C07D417/02, C 07D 4 7/02
US Classification:
435/117000, 435/252300, 435/123000, 544/333000, 546/148000, 546/167000, 546/281700, 548/204000
Abstract:
Recombinant Myxococcus host cells can be used to produce polyketides, including epothilone and epothilone analogs that can be purified from the fermentation broth and crystallized.
Leptomycin Compounds
US Patent:
7655808, Feb 2, 2010
Filed:
Sep 30, 2008
Appl. No.:
12/241218
Inventors:
Steven D. Dong - San Francisco CA, US
Daniel V. Santi - San Francisco CA, US
David C. Myles - Kensington CA, US
Brian Hearn - San Francisco CA, US
Daniel V. Santi - San Francisco CA, US
David C. Myles - Kensington CA, US
Brian Hearn - San Francisco CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 413/00, C07D 309/30
US Classification:
549293, 544149
Abstract:
Leptomycin-type compounds according to formula I.